SPL 7.14% 10.5¢ starpharma holdings limited

Ann: DEP HER2-lutetium outperforms in human breast cancer model, page-29

  1. 650 Posts.
    lightbulb Created with Sketch. 52
    You've probably missed the point(s).

    It might be an opinion only but probably shows how much value someone should put on that opinion. Although I also get a bit sick of the bickering but it's a two way street.

    This isn't just "old news", it's pretty relevant to the "new news" released today and I appreciate the thread being raised even just to have easy access to the announcement.


    Last edited by timferris: 26/04/23
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.